Decoy Therapeutics Inc. (DCOY) Return on equity 2016–2022
Decoy Therapeutics Inc. (DCOY) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-304.4%FY2022 · since FY2016: -66.6% → -304.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -304.4% | -271.4 pp |
| FY2021 | -33.0% | +0.2 pp |
| FY2020 | -33.2% | +32.4 pp |
| FY2019 | -65.6% | — |
| FY2016 | -66.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice